Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
Karen Slattery, Elena Woods, Vanessa Zaiatz-Bittencourt, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 2, pp. e002044-e002044
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
Xueke Shi, Jin Yang, Shuzhi Deng, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 106
Diet, lipids, and antitumor immunity
Hannah Prendeville, Lydia Lynch
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 3, pp. 432-444
Open Access | Times Cited: 77
TGF-β, EMT, and resistance to anti-cancer treatment
Xuecong Wang, Pieter J.A. Eichhorn, Jean Paul Thiery
Seminars in Cancer Biology (2023) Vol. 97, pp. 1-11
Open Access | Times Cited: 52
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 51
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Wenkang Wang, Yang Liu, Zhen He, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 42
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Leveraging NKG2D Ligands in Immuno-Oncology
Mercedes B. Fuertes, Carolina I. Domaica, Norberto W. Zwirner
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 93
Engineering the next generation of CAR-NK immunotherapies
Alexander Biederstädt, Katayoun Rezvani
International Journal of Hematology (2021) Vol. 114, Iss. 5, pp. 554-571
Open Access | Times Cited: 64
The Interplay Between TGF-β Signaling and Cell Metabolism
Huidong Liu, Ye‐Guang Chen
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 48
Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
Tatjana Sauerer, Giuliano Filippini Velázquez, Christoph Schmid
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 34
Natural killer cells and type 1 innate lymphoid cells in cancer
Noëlla Lopes, Éric Vivier, Émilie Narni-Mancinelli
Seminars in Immunology (2023) Vol. 66, pp. 101709-101709
Open Access | Times Cited: 26
NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential
Federica Portale, Diletta Di Mitri
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9521-9521
Open Access | Times Cited: 26
Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 23
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Tianye Li, Mengke Niu, Jianwei Zhou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Haixia Zhang, Shizhen Li, Dan Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment
Adnan Moinuddin, Sophie M. Poznanski, Ana L. Portillo, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 19-39
Closed Access | Times Cited: 8
Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy
Chloe Choi, David K. Finlay
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy
Wanze Zhang, Zhenghua Zhao, Fan Li
Molecular Immunology (2022) Vol. 144, pp. 58-70
Open Access | Times Cited: 37
GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT
Dongyao Wang, Zimin Sun, Xiaoyu Zhu, et al.
Blood (2022) Vol. 140, Iss. 26, pp. 2788-2804
Open Access | Times Cited: 36
Metabolic regulation of NK cell function: implications for immunotherapy
Hyogon Sohn, Megan A. Cooper
Immunometabolism (2023) Vol. 5, Iss. 1, pp. e00020-e00020
Open Access | Times Cited: 21
Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer
Deli Mao, Zhijun Zhou, Hengxing Chen, et al.
Cancer Letters (2023) Vol. 572, pp. 216351-216351
Open Access | Times Cited: 18
Rise of the natural red pigment ‘prodigiosin’ as an immunomodulator in cancer
Mohammed Moustapha Anwar, Chris Albanese, Nadia Μ. Hamdy, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
Minjie Wang, Zijie Zhou, Xuan Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 22
Advances in natural killer cell therapies for breast cancer
Seyedeh Zahra Fotook Kiaei, Alireza Nouralishahi, Mohammad Ghasemirad, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 8, pp. 705-726
Open Access | Times Cited: 15
Metabolism of NK cells during viral infections
Kenia Y. Osuna-Espinoza, Adrián G. Rosas-Taraco
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top